Doximity, Inc.
DOCSNYSEHealthcare● Active
$20.59
$-0.11(-0.53%)
Market Cap$3.9B
P/E Ratio—
52W High$76.51
52W Low$17.15
Doximity, Inc. (DOCS) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
DOCS · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 13, 2026EPS Actual
$0.26
Est. $0.28 · -7.1%
Revenue
$0.15B
Est. $0.14B · +0.9%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 13, 2026
After Market Close
▼ Miss EPS
DOCS reports quarterly as a NYSE-listed Medical - Healthcare Information Services company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | $0.29 | — | — | — | $0.15B | — |
| ▼ Q2 FY2026 | May 13, 2026 | $0.28 | $0.26 | -7.1% | $0.15B | $0.14B | +0.9% |
| ▲ Q1 FY2026 | Feb 5, 2026 | $0.44 | $0.46 | +4.5% | $0.19B | $0.18B | +1.9% |
| ▲ Q4 FY2025 | Nov 6, 2025 | $0.38 | $0.45 | +18.8% | $0.17B | $0.16B | +6.7% |
| ▲ Q3 FY2025 | Aug 7, 2025 | $0.30 | $0.36 | +19.4% | $0.15B | $0.14B | +4.6% |
| ▲ Q2 FY2025 | May 15, 2025 | $0.27 | $0.38 | +39.9% | $0.14B | $0.13B | +3.4% |
| ▲ Q1 FY2025 | Feb 6, 2025 | $0.31 | $0.45 | +45.2% | $0.17B | $0.13B | +25.7% |
| ▲ Q4 FY2024 | Nov 7, 2024 | $0.25 | $0.30 | +20.0% | $0.14B | $0.13B | +7.6% |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
$0.29
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 13, 2026Miss
EPS Actual
$0.26
EPS Est.
$0.28
EPS Surpr.
-7.1%
Revenue
$0.15B
Q1 FY2026
Feb 5, 2026Beat
EPS Actual
$0.46
EPS Est.
$0.44
EPS Surpr.
+4.5%
Revenue
$0.19B
Q4 FY2025
Nov 6, 2025Beat
EPS Actual
$0.45
EPS Est.
$0.38
EPS Surpr.
+18.8%
Revenue
$0.17B
Q3 FY2025
Aug 7, 2025Beat
EPS Actual
$0.36
EPS Est.
$0.30
EPS Surpr.
+19.4%
Revenue
$0.15B
Q2 FY2025
May 15, 2025Beat
EPS Actual
$0.38
EPS Est.
$0.27
EPS Surpr.
+39.9%
Revenue
$0.14B
Q1 FY2025
Feb 6, 2025Beat
EPS Actual
$0.45
EPS Est.
$0.31
EPS Surpr.
+45.2%
Revenue
$0.17B
Q4 FY2024
Nov 7, 2024Beat
EPS Actual
$0.30
EPS Est.
$0.25
EPS Surpr.
+20.0%
Revenue
$0.14B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2028 | $0.35 | $0.36 | $0.38 | 7 |
| Q4 FY2027 | $0.47 | $0.49 | $0.52 | 5 |
| Q3 FY2027 | $0.40 | $0.42 | $0.44 | 5 |
| Q2 FY2027 | $0.34 | $0.35 | $0.37 | 5 |
| Q1 FY2027 | $0.30 | $0.31 | $0.33 | 5 |
| Q4 FY2026 | $0.43 | $0.44 | $0.46 | 10 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2028 | $0.2B | $0.2B | $0.2B | 5 |
| Q4 FY2027 | $0.2B | $0.2B | $0.2B | 6 |
| Q3 FY2027 | $0.2B | $0.2B | $0.2B | 6 |
| Q2 FY2027 | $0.2B | $0.2B | $0.2B | 6 |
| Q1 FY2027 | $0.1B | $0.2B | $0.2B | 6 |
| Q4 FY2026 | $0.2B | $0.2B | $0.2B | 6 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 13, 2026 | -7.1% | $26.45 | $23.39 | -11.57% |
| ▲ Q1 FY2026 | Feb 5, 2026 | +4.5% | $35.25 | $33.32 | -5.48% |
| ▲ Q4 FY2025 | Nov 6, 2025 | +18.8% | $63.99 | $62.58 | -2.20% |
| ▲ Q3 FY2025 | Aug 7, 2025 | +19.4% | $58.13 | $58.55 | +0.72% |
| ▲ Q2 FY2025 | May 15, 2025 | +39.9% | $59.50 | $58.45 | -1.76% |
| ▲ Q1 FY2025 | Feb 6, 2025 | +45.2% | $58.14 | $58.26 | +0.21% |
| ▲ Q4 FY2024 | Nov 7, 2024 | +20.0% | $42.35 | $43.42 | +2.53% |
| ▲ Q3 FY2024 | Aug 8, 2024 | +27.3% | $25.50 | $25.66 | +0.63% |
Q2 FY2026-11.57%
Report Date
May 13, 2026
EPS Beat/Miss
-7.1%
Price Before
$26.45
Price After
$23.39
Q1 FY2026-5.48%
Report Date
Feb 5, 2026
EPS Beat/Miss
+4.5%
Price Before
$35.25
Price After
$33.32
Q4 FY2025-2.20%
Report Date
Nov 6, 2025
EPS Beat/Miss
+18.8%
Price Before
$63.99
Price After
$62.58
Q3 FY2025+0.72%
Report Date
Aug 7, 2025
EPS Beat/Miss
+19.4%
Price Before
$58.13
Price After
$58.55
Q2 FY2025-1.76%
Report Date
May 15, 2025
EPS Beat/Miss
+39.9%
Price Before
$59.50
Price After
$58.45
Q1 FY2025+0.21%
Report Date
Feb 6, 2025
EPS Beat/Miss
+45.2%
Price Before
$58.14
Price After
$58.26
Q4 FY2024+2.53%
Report Date
Nov 7, 2024
EPS Beat/Miss
+20.0%
Price Before
$42.35
Price After
$43.42
Q3 FY2024+0.63%
Report Date
Aug 8, 2024
EPS Beat/Miss
+27.3%
Price Before
$25.50
Price After
$25.66
Avg Beat Reaction-0.76%
Avg Miss Reaction-11.57%
Beat Rate7 / 8 quarters
Largest Move-11.57% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: DOCS ends December
Doximity, Inc. (DOCS) most recently reported earnings on May 13, 2026 for Q2 FY2026, posting EPS of $0.26 — missing the analyst consensus of $0.28 by -7.1%. The next DOCS earnings date is expected around September 1, 2026.
Each quarter, investors track DOCS earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. DOCS revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
DOCS's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
DOCS earnings · 5 questionsDoximity, Inc.'s next earnings report is expected around September 1, 2026. DOCS typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; DOCS historically reports after market close (AMC).
DOCS earnings datewhen is DOCS earningsDOCS next earnings datewhen does DOCS report earningsDOCS earnings calendar
▸ Source: FMP · Doximity, Inc. SEC filings · US GAAP · Doximity, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026